Spring Pharmaceutical Group (Spring Pharmaceutical Group) Cash-to-Debt : No Debt ⁽¹⁾ (As of Mar. 2019)

Spring Pharmaceutical Group Cash-to-Debt Chart

Spring Pharmaceutical Group Annual Data
	Trend	Mar10	Mar11	Mar12	Mar13	Mar14	Mar15	Mar16	Mar17	Mar18	Mar19
Cash-to-Debt		Get a 7-Day Free Trial					No Debt	No Debt	No Debt	No Debt	No Debt

Spring Pharmaceutical Group Quarterly Data
	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19
Cash-to-Debt	Get a 7-Day Free Trial															No Debt	No Debt	No Debt	No Debt	No Debt

Competitive Comparison of Spring Pharmaceutical Group's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Spring Pharmaceutical Group's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Spring Pharmaceutical Group's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Spring Pharmaceutical Group's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Spring Pharmaceutical Group's Cash-to-Debt falls into.

Spring Pharmaceutical Group Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Spring Pharmaceutical Group's Cash to Debt Ratio for the fiscal year that ended in Mar. 2019 is calculated as:

Spring Pharmaceutical Group had no debt ⁽¹⁾.

Spring Pharmaceutical Group's Cash to Debt Ratio for the quarter that ended in Mar. 2019 is calculated as:

Spring Pharmaceutical Group had no debt ⁽¹⁾.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Spring Pharmaceutical Group  (OTCPK:CYIG) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Spring Pharmaceutical Group Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Spring Pharmaceutical Group's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Spring Pharmaceutical Group (Spring Pharmaceutical Group) Business Description